Prodromic Inflammatory–Oxidative Stress in Peritoneal Leukocytes of Triple-Transgenic Mice for Alzheimer’s Disease

Inflammatory–oxidative stress is known to be pivotal in the pathobiology of Alzheimer’s disease (AD), but the involvement of this stress at the peripheral level in the disease’s onset has been scarcely studied. This study investigated the pro-inflammatory profile and oxidative stress parameters in peritoneal leukocytes from female triple-transgenic mice for AD (3xTgAD) and non-transgenic mice (NTg). Peritoneal leukocytes were obtained at 2, 4, 6, 12, and 15 months of age. The concentrations of TNFα, INFγ, IL-1β, IL-2, IL-6, IL-17, and IL-10 released in cultures without stimuli and mitogen concanavalin A and lipopolysaccharide presence were measured. The concentrations of reduced glutathione (GSH), oxidized glutathione (GSSG), lipid peroxidation, and Hsp70 were also analyzed in the peritoneal cells. Our results showed that although there was a lower release of pro-inflammatory cytokines by 3xTgAD mice, this response was uncontrolled and overstimulated, especially at a prodromal stage at 2 months of age. In addition, there were lower concentrations of GSH in leukocytes from 3xTgAD and higher amounts of lipid peroxides at 2 and 4 months, as well as, at 6 months, a lower concentration of Hsp70. In conclusion, 3xTgAD mice show a worse pro-inflammatory response and higher oxidative stress than NTg mice during the prodromal stages, potentially supporting the idea that Alzheimer’s disease could be a consequence of peripheral alteration in the leukocyte inflammation–oxidation state.

[1]  N. Ip,et al.  Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology , 2023, Journal of neurochemistry.

[2]  A. Macpherson,et al.  Boundaries and integration between microbiota, the nervous system, and immunity. , 2023, Immunity.

[3]  C. Morén,et al.  Antioxidant Therapeutic Strategies in Neurodegenerative Diseases , 2022, International journal of molecular sciences.

[4]  M. De la Fuente,et al.  Prematurely aging female mice improve their behavioural response, immunity, redox state, and lifespan after a short social interaction with non-prematurely aging mice , 2022, Biogerontology.

[5]  P. Madhavan,et al.  A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer’s disease , 2022, The International journal of neuroscience.

[6]  T. Saleh,et al.  Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease , 2022, Antioxidants.

[7]  Lin F. Yang,et al.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.

[8]  L. Velloso,et al.  Hippocampal Function Is Impaired by a Short-Term High-Fat Diet in Mice: Increased Blood–Brain Barrier Permeability and Neuroinflammation as Triggering Events , 2021, Frontiers in Neuroscience.

[9]  I. Appollonio,et al.  Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery? , 2021, Diagnostics.

[10]  M. De la Fuente The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease. , 2021, Journal of Alzheimer's disease : JAD.

[11]  F. Saravia,et al.  Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease , 2021, Frontiers in Neuroscience.

[12]  J. Kipnis,et al.  Neuromodulation by the immune system: a focus on cytokines , 2021, Nature Reviews Immunology.

[13]  P. González,et al.  "Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials". , 2021, Pharmacological research.

[14]  D. Weaver Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system , 2020, Alzheimer's & dementia.

[15]  M. Emoto,et al.  Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort , 2020, Journal of atherosclerosis and thrombosis.

[16]  P. Oliver,et al.  ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease , 2020, Antioxidants.

[17]  J. Lukens,et al.  The role of innate immunity in Alzheimer's disease , 2020, Immunological reviews.

[18]  S. Bakker,et al.  Oxidative stress is associated with suspected non‐alcoholic fatty liver disease and all‐cause mortality in the general population , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[19]  M. De la Fuente,et al.  Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[20]  K. Abe,et al.  Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements , 2020, International journal of molecular sciences.

[21]  S. Papageorgiou,et al.  Current and Future Treatments in Alzheimer Disease: An Update , 2020, Journal of central nervous system disease.

[22]  A. A. de Castro,et al.  Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the Oxidative Stress Hypothesis , 2019, Molecules.

[23]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[24]  C. Loreto,et al.  Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease model , 2019, Journal of Neuroinflammation.

[25]  T. Littlejohns,et al.  Association of Lifestyle and Genetic Risk With Incidence of Dementia. , 2019, JAMA.

[26]  P. Newhouse,et al.  The Role of Estrogen in Brain and Cognitive Aging , 2019, Neurotherapeutics.

[27]  M. Cosentino,et al.  Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease. , 2019, Current medicinal chemistry.

[28]  Roberta Diaz Brinton,et al.  Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan , 2019, Front. Endocrinol..

[29]  B. Schöttker,et al.  Oxidative stress and epigenetic mortality risk score: associations with all-cause mortality among elderly people , 2019, European Journal of Epidemiology.

[30]  S. Hébert,et al.  Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease , 2019, Journal of Neuroinflammation.

[31]  A. Angiolillo,et al.  Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression? , 2018, Journal of Neuroinflammation.

[32]  A. Caccamo,et al.  Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice , 2018, Aging cell.

[33]  R. Lathe,et al.  The antimicrobial protection hypothesis of Alzheimer's disease , 2018, Alzheimer's & Dementia.

[34]  B. Lamb,et al.  Inflammation as a central mechanism in Alzheimer's disease , 2018, Alzheimer's & dementia.

[35]  W. Petri,et al.  The Impact of Systemic Inflammation on Neurodevelopment. , 2018, Trends in molecular medicine.

[36]  M. D. Giudice,et al.  Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters , 2018, Brain, Behavior, and Immunity.

[37]  D. Bailey,et al.  13 reasons why the brain is susceptible to oxidative stress , 2018, Redox biology.

[38]  M. De la Fuente,et al.  Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress , 2018, Front. Immunol..

[39]  V. Gotta,et al.  Cytokine profiling in healthy children shows association of age with cytokine concentrations , 2017, Scientific Reports.

[40]  Alan J. Thomas,et al.  Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[41]  M. Grobusch,et al.  Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children—A Systematic Review , 2017, Front. Pediatr..

[42]  M. Fernández-Fernández,et al.  Hsp70 – a master regulator in protein degradation , 2017, FEBS letters.

[43]  A. Carvalho,et al.  Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[44]  R. Thangavel,et al.  Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration , 2017, Front. Cell. Neurosci..

[45]  G. Gigli,et al.  Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients , 2017, Neurodegenerative Diseases.

[46]  M. De la Fuente,et al.  An Appropriate Modulation of Lymphoproliferative Response and Cytokine Release as Possible Contributors to Longevity , 2017, International journal of molecular sciences.

[47]  Hyun Kim,et al.  Serum tumour necrosis factor‐α and interleukin‐6 levels in Alzheimer's disease and mild cognitive impairment , 2017, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[48]  C. Borlongan,et al.  When friend turns foe: central and peripheral neuroinflammation in central nervous system injury , 2017, Neuroimmunology and neuroinflammation.

[49]  K. Suk,et al.  Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis , 2017, Journal of the Neurological Sciences.

[50]  S. Allan,et al.  Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection , 2017, Journal of Neuroinflammation.

[51]  M. Baquero,et al.  Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease , 2017, Journal of the Neurological Sciences.

[52]  E. Ortega,et al.  Hsp70 basal levels, a tissue marker of the rate of aging and longevity in mice , 2016, Experimental Gerontology.

[53]  Zhijun Zhang,et al.  Inflammatory Cytokines and Alzheimer’s Disease: A Review from the Perspective of Genetic Polymorphisms , 2016, Neuroscience Bulletin.

[54]  Jennifer K. Blakemore,et al.  Aromatase: Contributions to Physiology and Disease in Women and Men. , 2016, Physiology.

[55]  Xiaoling Zhou,et al.  An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels. , 2016, American journal of translational research.

[56]  M. De la Fuente,et al.  The role of Hsp70 in oxi-inflamm-aging and its use as a potential biomarker of lifespan , 2015, Biogerontology.

[57]  J. Chan,et al.  Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus , 2015, Journal of Biomedical Science.

[58]  H. Brenner,et al.  Oxidative stress markers and all-cause mortality at older age: a population-based cohort study. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[59]  D. Talwar,et al.  Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study , 2015, PloS one.

[60]  James A. Eddy,et al.  IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.

[61]  M. Guillot-Sestier,et al.  Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology , 2015, Neuron.

[62]  J. Cruces,et al.  Function and redox state of peritoneal leukocytes as preclinical and prodromic markers in a longitudinal study of triple-transgenic mice for Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[63]  I. Aleksic,et al.  Peritoneal exudate cells from long-lived rats exhibit increased IL-10/IL-1β expression ratio and preserved NO/urea ratio following LPS-stimulation in vitro , 2014, AGE.

[64]  Antonio Ayala,et al.  Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal , 2014, Oxidative medicine and cellular longevity.

[65]  M. Heneka,et al.  Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview , 2014, Molecular Neurobiology.

[66]  A. Reiner,et al.  Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[67]  Michael W. Weiner,et al.  The future of blood-based biomarkers for Alzheimer's disease , 2014, Alzheimer's & Dementia.

[68]  M. Alberoni,et al.  A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[69]  R. Morishita,et al.  Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model , 2013, Neurobiology of Aging.

[70]  Jung-Eun Lee,et al.  An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions , 2013, Experimental neurobiology.

[71]  L. Monasta,et al.  Cytokine Levels in the Serum of Healthy Subjects , 2013, Mediators of inflammation.

[72]  C. Holmes Review: Systemic inflammation and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.

[73]  A. Boveris,et al.  Lipid Peroxidation: Chemical Mechanism, Biological Implications and Analytical Determination , 2012 .

[74]  M. D. Mayas,et al.  Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia , 2012, Experimental Gerontology.

[75]  M. De la Fuente,et al.  Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer's disease , 2012, Annals of the New York Academy of Sciences.

[76]  H. Besedovsky,et al.  Hsp72, inflammation, and aging: causes, consequences, and perspectives , 2012, Annals of the New York Academy of Sciences.

[77]  G. Ricevuti,et al.  Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. , 2011, Autoimmunity reviews.

[78]  D. Butterfield,et al.  Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. , 2011, Biochimica et biophysica acta.

[79]  C. Meisinger,et al.  Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study , 2011, AGE.

[80]  I. Grundke‐Iqbal,et al.  Alzheimer's disease, a multifactorial disorder seeking multitherapies , 2010, Alzheimer's & Dementia.

[81]  R. Dyck,et al.  Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes , 2010, Brain Research.

[82]  K. Duan,et al.  Inflammation: a bridge between postoperative cognitive dysfunction and Alzheimer's disease. , 2010, Medical hypotheses.

[83]  Bengt Winblad,et al.  Biomarkers for Alzheimer’s disease and other forms of dementia: Clinical needs, limitations and future aspects , 2010, Experimental Gerontology.

[84]  O. Forlenza,et al.  Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment , 2009, Dementia and Geriatric Cognitive Disorders.

[85]  M. Eyrich,et al.  Age-related changes in intracellular cytokine expression in healthy children. , 2009, European cytokine network.

[86]  J. Sayre,et al.  Immune blood biomarkers of Alzheimer disease patients , 2009, Journal of Neuroimmunology.

[87]  M. Block,et al.  NADPH oxidase as a therapeutic target in Alzheimer's disease , 2008, BMC Neuroscience.

[88]  M. De la Fuente,et al.  Gender-Specific Neuroimmunoendocrine Aging in a Triple-Transgenic 3×Tg-AD Mouse Model for Alzheimer’s Disease and Its Relation with Longevity , 2008, Neuroimmunomodulation.

[89]  P. Moreira,et al.  Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. , 2008, Free radical biology & medicine.

[90]  P. Gil,et al.  Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. , 2008, Immunology letters.

[91]  A. Lewandowska,et al.  Chaperones in control of protein disaggregation , 2008, The EMBO journal.

[92]  J. Dayer,et al.  The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors , 2007, Arthritis research & therapy.

[93]  Claudius Mueller,et al.  Increased production of inflammatory cytokines in mild cognitive impairment , 2007, Experimental Gerontology.

[94]  N. Kraut,et al.  Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition , 2007, Proteomics.

[95]  H. Besedovsky,et al.  Physiology of psychoneuroimmunology: A personal view , 2007, Brain, Behavior, and Immunity.

[96]  B. Brenner,et al.  Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. , 2006, Kidney international.

[97]  A. Chauhan,et al.  Oxidative stress in Alzheimer's disease. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.

[98]  V. Mathura,et al.  Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease , 2005, Journal of Neuroinflammation.

[99]  S. Levison,et al.  Interleukin‐1: A master regulator of neuroinflammation , 2004, Journal of neuroscience research.

[100]  J. Streffer,et al.  Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy , 2004, Molecular Psychiatry.

[101]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[102]  I. Appollonio,et al.  Peripheral cytokine release in Alzheimer patients: correlation with disease severity , 2003, Neurobiology of Aging.

[103]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[104]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[105]  Virginia M. Y. Lee,et al.  Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.

[106]  A K Manatunga,et al.  Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.

[107]  J. Barnes,et al.  Oxidative signalling and inflammatory pathways in Alzheimer's disease. , 2001, Biochemical Society symposium.

[108]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[109]  J. Chipeta,et al.  CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age. , 1998, Cellular immunology.

[110]  R. Hendricks,et al.  Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. , 1997, Journal of immunology.

[111]  H. Besedovsky,et al.  Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.

[112]  S. Araga,et al.  Serum interleukin‐2 levels in patients with dementia of the Alzheimer type , 1991, Acta neurologica Scandinavica.

[113]  R. Hilf,et al.  A fluorometric method for determination of oxidized and reduced glutathione in tissues. , 1976, Analytical biochemistry.

[114]  M. De la Fuente,et al.  Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.

[115]  M. Fuente Oxidation and Inflammation in the Immune and Nervous Systems, a Link Between Aging and Anxiety , 2018 .

[116]  M. Rey Bio-Psycho-Social Bridge: The Psychoneuroimmune System in Successful Aging , 2018 .

[117]  H. Besedovsky,et al.  Immune-Neuro-Endocrine Reflexes, Circuits, and Networks: Physiologic and Evolutionary Implications. , 2017, Frontiers of hormone research.

[118]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[119]  H. Besedovsky,et al.  Central and Peripheral Cytokines Mediate Immune-Brain Connectivity , 2010, Neurochemical Research.

[120]  M. D. de Leon,et al.  Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. , 2008, Journal of Alzheimer's disease : JAD.

[121]  A. Valentine,et al.  Neurobehavioral effects of interferon therapy , 2005, Current psychiatry reports.

[122]  H. Feldman,et al.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[123]  J. Whittum-Hudson,et al.  Infectious agents and Alzheimer's Disease. , 2003 .

[124]  A. Valenzuela,et al.  The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. , 1991, Life sciences.